Intestine Transplant Recipient Registration (TRR)

Data System for Organ Procurement and Transplantation Network

Intestine Transplant Recipient Registration_TRR Instructions

Intestine Transplant Recipient Registration (TRR)

OMB: 0915-0157

Document [docx]
Download: docx | pdf

Intestine Transplant Recipient Registration (TRR) Field Descriptions

Transplant Recipient Registration (TRR) records are generated and available immediately after a transplant event is reported through the recipient feedback process in WaitlistSM. Forms are generated by the age at transplant, not the age at listing. The TRR record is completed by the transplant center performing the transplant. The registration and hospital discharge follow-up information is combined in this record.

Complete the TRR at hospital discharge or six weeks post transplant, whichever is first. If the recipient is still hospitalized at six weeks post transplant, provide data regarding the recipient’s progress consistent with the six-week time frame.

The TRR must be validated within 90 days of the record generation date. Example: If the recipient is removed as being transplanted on 10/1/XXXX, the TRR form will be due 90 days from that date, 12/30/XXXX. See OPTN Policies for additional information. Use the search feature to locate specific policy information on Data Submission Requirements.

To correct information that is already displayed on an electronic record, call the UNetSM Help Desk at 1-800-978-4334.

Additional Resources: See History of Definition Changes.

Recipient Information

Name: Verify the last name, first name and middle initial of the transplant recipient is correct. If the information is incorrect, corrections may be made on the recipient's TCR record.

DOB: Verify the displayed date is the recipient's date of birth. If the information is incorrect, corrections may be made on the recipient's TCR record.

SSN: Verify the recipient's social security number is correct. If the information is incorrect, contact the Help Desk at 1-800-978-4334.

Gender: Verify recipient’s sex (Male or Female), based on biologic and physiologic traits, at birth. If sex at birth is unknown, report sex at time of registration as reported by recipient or documented in medical record. The intent of this data collection field is to capture physiologic characteristics that may have an impact on recipient size matching or graft outcome. If the information is incorrect, corrections may be made on the recipient's TCR record.

HIC: Verify the 9 to 11 character Health Insurance Claim number for the recipient indicated on the recipient's most recently updated TCR record is correct. If the recipient does not have a HIC number, you may leave this field blank.

Transplant Date: Verify that the displayed transplant date is correct. The transplant date is determined by the start of the organ anastomosis during transplant or the start of the islet infusion. Organ transplants include solid organ transplants and islet infusions. An organ transplant procedure is complete when any of the following occurs:

The chest or abdominal cavity is closed and the final skin stitch or staple is applied.

The transplant recipient leaves the operating room, even if the chest or abdominal cavity cannot be closed.

The islet infusion is complete.

State of Permanent Residence: Select the name of the state of the recipient's permanent address at the time of transplant (location of full-time residence, not transplant center location). This field is required. (List of State codes)

Permanent Zip Code: Enter the recipient's permanent zip code at the time of transplant (location of full-time residence, not transplant center location). This field is required.

Provider Information

Recipient Center: The Recipient Center information reported in Waitlist displays. Verify that the center information is the hospital where the transplant operation was performed. The Provider Number is the 6-character Medicare identification number of the hospital. This is followed by the Center Code and Center Name.

Surgeon Name: Enter the name of the primary surgeon, who performed the transplant operation, and under whose name the transplant is billed. This field is required.

NPI #: Enter the 10-character CMS (Center for Medicare and Medicaid Services) assigned National Provider Identifier of the transplant surgeon. Your hospital billing office may be able to obtain this number for you. This field is required.

Donor Information

UNOS Donor ID #: The donor ID number, reported in the Recipient Feedback, will display. Each potential donor is assigned an identification number by the OPTN. This ID number corresponds to the date the donor information was entered into the OPTN computer system.

Recovering OPO: The Organ Procurement Organization (OPO) code will display. Verify the code is correct.

Donor Type: The donor type, reported in the Recipient Feedback, will display. Verify the recipient's donor type is correct. If the information is incorrect, contact the Help Desk at 1-800-978-4334.

Deceased indicates the donor was not living at the time of donation.
Living
indicates the donor was living at the time of donation.

Patient Status

Primary Diagnosis: Select the primary diagnosis for the disease requiring a transplant for this recipient. If the recipient has had a previous transplant for the same organ type, select Retransplant/Graft Failure as the primary diagnosis for that organ. If Other, Specify is selected, enter the primary diagnosis in the space provided. The primary diagnosis should not be changed to concur with the pathology confirmed diagnosis. The primary diagnosis field should reflect information known at the time of transplant. This field is required. (List of Intestine Diagnosis codes)

Secondary Diagnosis: Select the secondary diagnosis for the disease requiring a transplant for this recipient. If Other, Specify is selected, enter the secondary diagnosis in the space provided. (List of Intestine Diagnosis codes)

Date: Last Seen, Retransplanted or Death: Complete at discharge (if discharged prior to six weeks from transplant date) or at six weeks from transplant date, whichever occurs first. Enter the date the hospital reported the recipient as living, retransplanted (when the data was obtained prior to the recipient's discharge) or the date of the recipient's death, using the standard 8-digit numeric format of MM/DD/YYYY. This field is required.

Patient Status: Complete at discharge (if discharged prior to six weeks from transplant date) or at six weeks from transplant date, whichever occurs first. Select the appropriate status for this recipient. If Dead is selected, indicate the cause of death. This field is required.

Living
Dead
Retransplanted

Primary Cause of Death: If the Patient Status is Dead, select the patient's cause of death. If an Other code is selected, enter the other cause of death in the space provided. (List of Primary Cause of Death codes)

Contributory Cause of Death: If the Patient Status is Dead, select the patient's contributory cause of death. If an Other code is selected, enter the other cause of death in the space provided. (List of Contributory Cause of Death codes)

Contributory Cause of Death: If the Patient Status is Dead, select the patient's contributory cause of death. If an Other code is selected, enter the other cause of death in the space provided. (List of Contributory Cause of Death codes)

Note: If the patient is being retransplanted, access the patient's last record for their previous transplant and select Retransplanted in the Patient Status field. This will stop the generation of TRF records associated with the previous transplant.

Transplant Hospitalization:

Date of Admission to Tx Center: Enter the date the recipient was admitted to the transplant center, using the 8-digit MM/DD/YYYY format. If the patient was admitted to the hospital before it was determined a transplant was needed, enter the date it was determined the patient needed a transplant. This field is required.

Date of Discharge From Tx Center: Enter the date the recipient was released to go home, using the 8-digit MM/DD/YYYY format. The recipient's hospital stay includes total time spent in different units of the hospital, including medical and rehab. This information is not required in the TRR record, but if entered here, it will automatically fill in the future TRF records. It is required in the TRF record.

Note: Leave this field blank if the recipient was removed from the waiting list with a code of 21, indicating the recipient died during the transplant procedure.

Clinical Information: PRETRANSPLANT

Medical Condition at time of transplant: Select the choice that best describes the recipient's condition and location just prior to the time of transplant. This field is required.  

IN INTENSIVE CARE UNIT - Patient was hospitalized and in the ICU prior to transplant preparation and the actual transplant.

HOSPITALIZED NOT IN ICU - Patient was hospitalized but not in the ICU prior to transplant preparation and the actual transplant.

NOT HOSPITALIZED - Patient was not hospitalized prior to transplant preparation and the actual transplant.

Patient on Life Support: If the patient was on life support at the time of transplant, select Yes. If not, select No. If Yes is selected, check all that apply. If a type of life support used is not listed select Other Mechanism, Specify and specify the type in the space provided. This field is required.

Ventilator - Select only if the recipient is on continuous invasive ventilation
Artificial Liver
Other Mechanism, Specify

Functional Status: Select the choice that best describes the recipient's functional status just prior to the time of transplant. This field is required.

Note: The Karnofsky Index will display for adults aged 18 and older.

100% - Normal, no complaints, no evidence of disease

90% - Able to carry on normal activity: minor symptoms of disease

80% - Normal activity with effort: some symptoms of disease

70% - Cares for self: unable to carry on normal activity or active work

60% - Requires occasional assistance but is able to care for needs

50% - Requires considerable assistance and frequent medical care

40% - Disabled: requires special care and assistance

30% - Severely disabled: hospitalization is indicated, death not imminent

20% - Very sick, hospitalization necessary: active treatment necessary

10% - Moribund, fatal processes progressing rapidly

Note: The Lansky Score will display for pediatrics aged less than 18.

100% - Fully active, normal

90% - Minor restrictions in physically strenuous activity

80% - Active, but tires more quickly

70% - Both greater restriction of and less time spent in play activity

60% - Up and around, but minimal active play; keeps busy with quieter activities

50% - Can dress but lies around much of day; no active play; can take part in quiet play/activities

40% - Mostly in bed; participates in quiet activities

30% - In bed; needs assistance even for quiet play

20% - Often sleeping; play entirely limited to very passive activities

10% - No play; does not get out of bed

Not Applicable (patient < 1 year old)

Unknown

Note: This evaluation should be in comparison to the person's normal function, indicating how the patient's disease has affected their normal function.

Cognitive Development: (This field is required for recipients 18 years of age or younger.) Select the choice that best describes the recipient's cognitive development just prior to the time of transplant.

Definite Cognitive Delay/Impairment (verified by IQ score <70 or unambiguous behavioral observation)

Probable Cognitive Delay/Impairment (not verified or unambiguous but more likely than not, based on behavioral observation or other evidence)

Questionable Cognitive Delay/Impairment (not judged to be more likely than not, but with some indication of cognitive delay/impairment such as expressive/receptive language and/or learning difficulties)

No Cognitive Delay/Impairment (no obvious indicators of cognitive delay/impairment)

Not Assessed

Motor Development: (This field is required for recipients 18 years of age or younger.) Select the choice that best describes the recipient's motor development just prior to the time of transplant.

Definite Motor Delay/Impairment (verified by physical exam or unambiguous behavioral observation)

Probable Motor Delay/Impairment (not verified or unambiguous but more likely than not, based on behavioral observation or other evidence)

Questionable Motor Delay/Impairment (not judged to be more likely than not, but with some indication of motor delay/impairment)

No Motor Delay/Impairment (no obvious indicators of motor delay/impairment)

Not Assessed

Academic Progress: (This field is required for recipients less than 18 years of age.) Select the choice that best describes the recipient's academic progress just prior to the time of transplant. If the recipient is less than 5 years old or has graduated from high school, select Not Applicable < 5 years old/High School graduate or GED.

Within One Grade Level of Peers
Delayed Grade Level
Special Education
Not Applicable <5 years old/High School graduate or GED
Status Unknown

Academic Activity Level: (This field is required for recipients less than 18 years of age.) Select the choice that best describes the recipient's academic activity level just prior to the time of transplant. If the recipient is less than 5 years old or has graduated from high school, select Not Applicable < 5 years old/High School graduate or GED.

Full academic load
Reduced academic load
Unable to participate in academics due to disease or condition
Not Applicable <5 years old/High School graduate or GED
Status Unknown

Working for income: (This field is required for recipients 18 years of age or older.) If the recipient was working for income just prior to the time of transplant, select Yes. If not, select No. If reporting the recipient's death, indicate if the recipient was working for income just prior to death.

Source of Payment:

Primary: Select as appropriate to indicate the recipient's source of primary payment (largest contributor) for the transplant. This field is required.  (List of Primary Insurance codes)

Private insurance refers to funds from agencies such as Blue Cross/Blue Shield, etc.  It also refers to any worker's compensation that is covered by a private insurer.

Public insurance - Medicaid refers to state Medicaid funds.

Public insurance - Medicare FFS (Fee-for-Service) refers to funds from the government in which doctors and other health care providers are paid for each service provided to a recipient. Includes Medicare part A, part B and part D. Medicare part A (hospital) must be in place to be considered primary payer. For additional information about Medicare, see http://www.medicare.gov/.

Public insurance - Medicare & Choice refers to funds from the government in which doctors and other health care providers are paid for each service provided to a recipient, along with additional benefits such as coordination of care or reducing-out-of-pocket expenses. Sometimes a recipient may receive additional benefits such as prescription drugs. For additional information about Medicare, see http://www.medicare.gov/.

Public insurance - CHIP (Children's Health Insurance Program)

Public insurance - Department of VA refers to funds from the Veterans Administration.

Public insurance - Other government

Self indicates that the recipient will pay for the cost of transplant.

Donation indicates that a company, institution, or individual(s) donated funds to pay for the transplant and care of the recipient.

Free Care indicates that the transplant hospital will not charge recipient for the costs of the transplant operation.

Foreign Government, Specify refers to funds provided by a foreign government (Primary only) Specify foreign country in the space provided. (List of Foreign Country codes)

Height Date of Measurement: (Complete for recipients 18 years of age or younger.) Enter the date, using the 8-digit format of MM/DD/YYYY, the recipient’s height was measured.

Height: Enter the height of the recipient, just prior to the time of transplant, in feet and inches or centimeters. If the recipient’s height is unavailable, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). (List of Status codes) For recipients 18 years old or younger at the time of transplant, UNet will generate and display calculated percentiles based on the 2000 CDC growth charts. This field is required.

Weight Date of Measurement: (Complete for recipients 18 years of age or younger.) Enter the date, using the 8-digit format of MM/DD/YYYY, the recipient’s weight was measured.

Weight: Enter the weight of the recipient, just prior to the time of transplant, in pounds or kilograms. If the recipient’s weight is unavailable, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). (List of Status codes) For recipients 18 years old or younger at the time of transplant, UNet will generate and display calculated percentiles based on the 2000 CDC growth charts. This field is required.

BMI (Body Mass Index): The recipient's BMI will display. For candidates less than 20 years of age at the time of transplant, UNet will generate and display calculated percentiles based on the 2000 CDC growth charts.

Percentiles are the most commonly used clinical indicator to assess the size and growth patterns of individual children in the United States. Percentiles rank the position of an individual by indicating what percent of the reference population the individual would equal or exceed (i.e. on the weight-for-age growth charts, a 5 year-old girl whose weight is at the 25th percentile, weighs the same or more than 25 percent of the reference population of 5-year-old girls, and weighs less than 75 percent of the 5-year-old girls in the reference population). For additional information about CDC growth charts, see http://www.cdc.gov/.

Note: Users who check the BMI percentiles against the CDC calculator may notice a discrepancy that is caused by the CDC calculator using 1 decimal place for height and weight and UNet using 4 decimal places for weight and 2 for height.

Previous Transplants: The three most recent transplant(s), indicated on the recipient's validated Transplant Recipient Registration (TRR) record(s), will display. Verify all previous transplants listed by organ type, transplant date and graft failure date.

Note: The three most recent transplants on record for this recipient will be displayed for verification. If there are any prior transplants that are not listed here, contact the UNet Help Desk at 1-800-978-4334 or unethelpdesk@unos.org to determine if the transplant event is in the database.

Viral Detection:

HIV Serostatus:  Select the serology results from the list. This field is required.

Positive
Negative
Not Done
UNK/Cannot Disclose

Definition: (Human Immunodeficiency Virus) - The virus that causes AIDS, which is the most advanced stage of HIV infection. HIV is a retrovirus that occurs as two types: HIV-1 and HIV-2. Both types are transmitted through direct contact with HIV-infected body fluids, such as blood, semen, and genital secretions, or from an HIV-infected mother to her child during pregnancy, birth, or breastfeeding (through breast milk).

CMV Status: Select the serology results from the list. If there is a positive CMV IgG or positive CMV Total Antibody result then CMV Status should be reported as positive. This field is required.

Positive
Negative
Not Done
UNK/Cannot Disclose

Definition: Cytomegalovirus - A herpesvirus (genus Cytomegalovirus) that causes cellular enlargement and formation of eosinophilic inclusion bodies especially in the nucleus and that acts as an opportunistic infectious agent in immunosuppressed conditions (as AIDS).

HBV Surface Antibody Total: Select the serology results from the list. This field is required.

Positive
Negative
Not Done
UNK/Cannot Disclose

HBV Core Antibody: Select the serology results from the list. This field is required.

Positive
Negative
Not Done
UNK/Cannot Disclose

Definition: Hepatitis B Virus - A sometimes fatal hepatitis caused by a double-stranded DNA virus (genus Orthohepadnavirus of the family Hepadnaviridae) that tends to persist in the blood serum and is transmitted especially by contact with infected blood (as by transfusion or by sharing contaminated needles in illicit intravenous drug use) or by contact with other infected bodily fluids (as during sexual intercourse) -- also called serum hepatitis.

HBV Surface Antigen: Select the serology results from the list. This field is required.

Positive
Negative
Not Done
UNK/Cannot Disclose

Definition: Hepatitis B Virus - A sometimes fatal hepatitis caused by a double-stranded DNA virus (genus Orthohepadnavirus of the family Hepadnaviridae) that tends to persist in the blood serum and is transmitted especially by contact with infected blood (as by transfusion or by sharing contaminated needles in illicit intravenous drug use) or by contact with other infected bodily fluids (as during sexual intercourse) -- also called serum hepatitis.

HCV Serostatus: Select the serology results from the list. This field is required.

Positive
Negative
Not Done
UNK/Cannot Disclose

Definition: Hepatitis C Virus - A disease caused by a flavivirus that is usually transmitted by parenteral means (as injection of an illicit drug, blood transfusion, or exposure to blood or blood products) and that accounts for most cases of non-A, non-B hepatitis.

EBV Serostatus: Select the serology results from the list. If there is a positive EBV IgG or positive EBV Total Antibody result then EBV Serostatus should be reported as positive. This field is required.

Positive
Negative
Not Done
UNK/Cannot Disclose

Definition: (Epstein-Barr Virus) - A herpesvirus (genus Lymphocryptovirus) that causes infectious mononucleosis and is associated with Burkitt's lymphoma and nasopharyngeal carcinoma -- abbreviation EBV; called also EB virus.

NAT (Nucleic Acid Test) Results:

HIV NAT: Select the NAT results from the list. This field is required.

Positive
Negative
Not Done
UNK/Cannot Disclose

Definition: (Human Immunodeficiency Virus) - The vrus that causes AIDS, which is the most advanced stage of HIV infection. HIV is a retrovirus that occurs as two types: HIV-1 and HIV-2. Both types are transmitted through direct contact with HIV-infected body fluids, such as blood, semen, and genital secretions, or from an HIV-infected mother to her child during pregnancy, birth, or breastfeeding (through breast milk).

HBV NAT: Select the NAT results from the list. This field is required.

Positive
Negative
Not Done
UNK/Cannot Disclose

Definition: (Hepatitis B Virus) - A virus which primarily causes inflammation of the liver. The hepatitis B virus can be transmitted in several ways including blood transfusion, needle sticks, body piercing and tattooing using unsterile instruments, dialysis, sexual and even less intimate close contact, and childbirth. Symptoms include fatigue, jaundice, nausea, vomiting, dark urine, and light stools.

HCV NAT: Select the NAT results from the list. This field is required.

Positive
Negative
Not Done
UNK/Cannot Disclose

Definition: (Hepatitis C Virus) - Inflammation of the liver due to the hepatitis C virus which is usually spread via blood transfusion (rare), hemodialysis, and needle sticks. The damage hepatitis C does to the liver can lead to cirrhosis and its complications as well as cancer. Transmission of the virus by sexual contact is rare. At least half of hepatitis C patients develop chronic hepatitis C infection. Diagnosis is made by blood test. Treatment and probably cure is via antiviral drugs and is effective in over 90% of patients. Chronic hepatitis C was frequently treated with injectable interferon, in combination with antiviral oral medications, but now is most often treated with oral antivirals alone.

Note: For an equivocal (or indeterminate) result that changes to either positive or negative, change the result to the newer more specific value even though it may be a different test date. For a result that was originally equivocal (or indeterminate) or remains equivocal (or indeterminate) after repeated testing, record as “UNK/cannot disclose".  

Did the recipient receive Hepatitis B vaccines prior to transplant?: If the recipient received Hepatitis B vaccines prior to transplant, select Yes. If not, select No. If unknown, select UNK. This field is required. If no, select one of the following:

Prior immunity
Medical precaution
Time constraints
Patient objection
Other, specify

Total Bilirubin: Enter the lab value for total serum bilirubin in mg/dl taken closest to the time of transplant. If the value is not available, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). This field is required.

Serum Albumin: Enter the lab value for the serum albumin value in g/dl taken closest to the time of transplant. If the value is not available, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). This field is required.

Serum Creatinine: Enter the lab value for the serum creatinine value in mg/dl taken closest to the time of transplant. If the value is not available, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). This field is required.

Clinical Information: TRANSPLANT PROCEDURE

Multiple Organ Recipient: Other organs that were reported as being transplanted in the Recipient Feedback will display. Verify the other organs transplanted at this time are correct. If incorrect, contact the Help Desk.

Were extra vessels used in the transplant procedure: If extra vessels (vascular allografts) were used in the transplant procedure, as indicated on the Waitlist Removal, Yes displays.

Vessel Donor ID: The donor ID entered on the Waitlist Removal displays. Donor IDs entered for this question must be from deceased donors. All deceased donor extra vessels must be monitored due to the potential for disease transmission.

Note: If the extra vessels used in a transplant procedure are procured from a tissue processing organization, they are not reported in UNet.

Procedure Information:

Intestine Venous Drainage: Indicate if the intestinal venous drainage was attached to Portal or Systemic circulation. This field is required.

Native Viscera Venous Drainage: Indicate if the native viscera venous drainage was attached to Portal or Systemic circulation. This field is required.

Procedure Type: Verify that the displayed procedure type is correct.

Whole Intestine
Intestine Segment
Whole Intestine with Pancreas (Technical Reasons)
Intestine Segment with Pancreas (Technical Reasons)

Organ Type: Select to indicate all intestinal organs transplanted into this recipient from the donor identified on the list below. This field is required.

Stomach
Small Intestine
Duodenum
Large Intestine

Preservation Information:

Total Ischemic Time (Include cold, warm and anastomotic time):  Enter the cumulative time between cessation of blood flow in the donor and revascularization of the intestinal organ in the recipient. If the time is not available, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). This field is required.

Note: Enter the time in hours and decimal parts of an hour. For example, 1 hour should be entered as "1", "1.0" or "1.00"; 1 hour and 30 minutes should be entered as "1.5" or "1.50" not "1.30".

To report the minutes, divide the number of minutes into 60 and record 2 decimal places. Example: 7hrs 19 minutes = 7.32   ( 60 divided by 19 =.32)

Note: Select N/A from the ST field for all Preservation Information if the recipient was removed from the waiting list with a code 21, indicating the recipient died during the transplant procedure.

Risk Factors:

For each of the risk factors listed, indicate the recipient's history of the risk factor at the time of this transplant.

Recent Septicemia: If the recipient has a history of septicemia requiring IV antibiotic medication during the two weeks prior to transplant select Yes. If not, select No. If unknown, select UNK. This field is required.

Exhausted Vascular Access: If the medical staff is unable to access the recipients vascular system for intravenous therapy at the time of transplant, select Yes. If not, select No. If unknown, select UNK. This field is required.

Previous Abdominal Surgery: If the recipient had any abdominal surgery prior to this transplant, select Yes. If not, select No. If unknown, select UNKThis field is required.

Dilated/Non-Functional Bowel Segments: If the recipient exhibited any dilated or non-functioning bowel segments at the time of transplant, select Yes. If not, select No. If unknown, select UNK. This field is required.

Other: If other risk factors were present at the time of transplant, enter the factors in the space provided.

Organ Check-In Date: Enter the date (MM/DD/YYYY) the organ arrives at the transplant hospital (prior to opening the organ’s external transport container).

Check-In Time: Enter the time the organ arrives at the transplant hospital (prior to opening the organ’s external transport container).

Note: Time should be in 24-hour format.

Clinical Information: POST TRANSPLANT

Graft Status: If the graft is functioning at the time of hospital discharge or six weeks post-transplant, select Functioning. If the graft is not functioning at the time of hospital discharge or six weeks post-transplant, select Failed. This field is required.

Note: Select Functioning if the recipient was removed from the waiting list with a code 21, indicating the recipient died during the transplant procedure.

Note: If death is indicated for the recipient, and the death was a result of some other factor unrelated to graft failure, select Functioning.

If Functioning, select Yes or No for each of the following fields:

TPN Dependent: If the recipient is dependent on total parenteral nutrition, select Yes. If not, select No.

IV Dependent: If the recipient is dependent on intravenous fluids, select Yes. If not, select No.

Oral Feeding: If the recipient is receiving oral nutrition, select Yes. If not, select No.

Tube Feed: If the recipient is receiving nutrition via any gastric tube, select Yes. If not, select No.

If Failed, provide the following information:

Date of Failure: Enter the date of graft failure using the standard 8-digit numeric format of MM/DD/YYYY.

Primary Cause of Graft Failure: Select the cause of graft failure. If Other Specify is selected, enter the cause of graft failure in the space provided. (List of Adult Graft Failure codes) (List of Pediatric Graft Failure codes)

Recurrent Tumor 
Acute Rejection 
Chronic Rejection 
Technical Problems 
Infection 
Lymphoproliferative Disease 
Graft Versus Host Disease
Ischemia/NEC (Necrotizing Enterocolitis) Like Syndrome
Other Specify

Did patient have any acute rejection episodes between transplant and discharge: If the recipient had any acute rejection episodes between transplant and discharge, select a Yes choice. If not, select No. This field is required.  (List of Any Acute Rejection Episodes codes)

Yes, at least one episode treated with anti-rejection agent
Yes, none treated with additional anti-rejection agent
No

Immunosuppressive Information

Are any medications given currently for maintenance or anti-rejection: If medications have been given to the recipient for maintenance or anti-rejection during the time between transplant and hospital discharge, or 6 weeks post-transplant if the recipient has not been discharged, select Yes. If not, select No. If Yes, complete the sections below. This field is required.

Definition of Immunosuppressive Medications

For each of the immunosuppressive medications listed, select Ind (Induction), Maint (Maintenance) or AR (Anti-rejection) to indicate all medications that were prescribed for the recipient during the initial transplant hospitalization period, and for what reason. If a medication was not given, leave the associated box(es) blank.  

Induction (Ind) immunosuppression includes all medications given for a short finite period in the perioperative period for the purpose of preventing acute rejection. Though the drugs may be continued after discharge for the first 30 days after transplant, it will not be used long-term for immunosuppressive maintenance. Induction agents are usually polyclonal, monoclonal, or IL-2 receptor antibodies (example: methylprednisolone, Campath, Thymoglobulin, or Simulect). Some of these drugs might be used for another finite period for rejection therapy and would be recorded as anti-rejection therapy if used for this reason. For each induction medication indicated, write the total number of days the drug was actually administered in the space provided. For example, if Simulect was given in 2 doses a week apart then the total number of days would be 2, even if the second dose was given after the patient was discharged.  

Maintenance (Maint) includes all immunosuppressive medications given before, during or after transplant with the intention to maintain them long-term (example: prednisone, cyclosporine, tacrolimus, mycophenolate mofetil, azathioprine, or Rapamune). This does not include any immunosuppressive medications given to treat rejection episodes, or for induction.  

Anti-rejection (AR) immunosuppression includes  all immunosuppressive medications given for the purpose of treating an acute rejection episode during the initial post-transplant period or during a specific follow-up period, usually up to 30 days after the diagnosis of acute rejection (example: methylprednisolone, or Thymoglobulin). When switching maintenance drugs (example: from tacrolimus to cyclosporine; or from mycophenolate mofetil to azathioprine) because of rejection, the drugs should not be listed under AR immunosuppression, but should be listed under maintenance immunosuppression.  

If an immunosuppressive medication other than those listed is being administered (e.g., new monoclonal antibodies), select Ind, Maint, or AR next to Other Immunosuppressive Medication field, and enter the full name of the medication in the space provided. Note: Do not list non-immunosuppressive medications.  

Drugs used for induction, acute rejection, or maintenance

Select the appropriate status from the applicable Status field (Missing, Unknown, N/A, Not Done).  

Steroids (prednisone, methylprednisolone, Solumedrol, Medrol) 

Drugs used for induction or acute rejection

Select the appropriate status from the applicable Status field (Missing, Unknown, N/A, Not Done).  

Atgam

Campath (alemtuzumab)

Cytoxan (cyclophosphamide)

Methotrexate (Folex PFS, Mexate-AQ, Rheumatrex)

Rituxan (rituximab)

Simulect (basiliximab)

Thymoglobulin

Drugs primarily used for maintenance

Select the appropriate status from the applicable Status field (Missing, Unknown, N/A, Not Done).  

Cyclosporine, select from the following:

  • Gengraf

  • Neoral

  • Sandimmune

  • Generic cyclosporine

  • Imuran (azathioprine, AZA)

  • Leflunomide (LFL)

Mycophenolic acid, select from the following:

  • CellCept (MMF)     

  • Generic MMF (generic CellCept)     

  • Myfortic (mycophenolic acid)     

  • Generic Myfortic (generic mycophenolic acid)

 mTOR inhibitors, select from the following:

  • Rapamune (sirolimus)     

  • Generic sirolimus     

  • Zortress (everolimus)

  • Nulojix (belatacept)

Tacrolimus, select from the following:

  • Astagraf XL (extended release tacrolimus)

  • Envarsus XR (tacrolimus XR)

  • Prograf (tacrolimus)

  • Generic tacrolimus (generic Prograf)

Other drugs

Select the appropriate status from the applicable Status field (Missing, Unknown, N/A, Not Done).  

Other immunosuppressive medication, specify:

12


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleIntestine Transplant Recipient Registration_TRR Instructions
AuthorAlex Garza
File Modified0000-00-00
File Created2023-07-29

© 2024 OMB.report | Privacy Policy